Faculty profile

Philippe Major

ResearcherNeurosciencesUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Philippe Major

Researcher

Neurosciences

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
19 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

331

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Biomarkers Epilepsy Immune System Tuberous Sclerosis Complex Genetics Intellectual Disability Inflammation

Latest papers

Do we agree on seizure reduction after vagus nerve stimulation? Interrater reliability of retrospective and prospective seizure frequency ratings from the CONNECTiVOS database.
Epilepsia · 2026
Brain-age defines a structural signature of outcomes after vagus nerve stimulation in children.
Brain stimulation · 2026
Personalized Virtual Brain Simulations and Vagus Nerve Stimulation Outcomes in Pediatric Epilepsy: A Multicenter Study From the CONNECTiVOS Collaboration.
Neuromodulation : journal of the International Neuromodulation Society · 2026

All 44 publications

Latest funding

Peripheral and CNS inflammation and injury profiles in children with Tuberous Sclerosis Complex and their association with neurological disability and treatment with mTOR inhibitors: a multicentre, longitudinal study cohort.
CIHR · 2025 · Principal investigator
$1,453,500
Neuroinflammation as a biomarker for epilepsy and neuropsychiatric comorbidities among people with tuberous sclerosis complex: a prospective, multicentre study
CIHR · 2022 · Principal investigator
$726,750

All 2 grants and awards

44 publications.

Do we agree on seizure reduction after vagus nerve stimulation? Interrater reliability of retrospective and prospective seizure frequency ratings from the CONNECTiVOS database.

Dinger TF, Mithani K, Al-Hasan HA, Yefet L, Niazi F, Suresh H, Wong SM, Danthine V, Berger A, Yau I, McRae L, Rutka JT, Christian EA, Weiss S, Sham L, Donner E, Chau V, Al-Johani H, Lima FL, Chandran A, Jabbarli R, Sure U, Hadjinicolaou A, Major P, Weil AG, Tailor J, Abel TJ, Remick M, Akwayena E, Schrader D, Bollo RJ, Smyth MD, Aum D, Lew S, Wang S, Niazi T, Raskin JS, Widjaja E, Weiner HL, Gadgil N, LoPresti MA, Fallah A, Kerr E, Jain P, Ibrahim GM

Epilepsia2026

DOI: 10.1111/epi.70031 PMID: 41319125

Brain-age defines a structural signature of outcomes after vagus nerve stimulation in children.

Latypov TH, Suresh H, Gouveia FV, Mithani K, Berger A, Wong SM, Coleman SC, Weiss S, Sham L, Chau V, Hadjinicolaou A, Major P, Weil AG, Tailor J, Abel TJ, Remick M, Akwayena E, Schrader D, Bollo RJ, Smyth MD, Aum D, Lew S, Wang S, Niazi T, Raskin JS, Widjaja E, Albert GW, Weiner HL, Gadgil N, LoPresti MA, Fallah A, Kerr EN, Jain P, Christian E, Donner E, Rutka JT, Ibrahim GM

Brain stimulation2026

DOI: 10.1016/j.brs.2026.103117 PMID: 42107526

Personalized Virtual Brain Simulations and Vagus Nerve Stimulation Outcomes in Pediatric Epilepsy: A Multicenter Study From the CONNECTiVOS Collaboration.

Berger A, Latypov T, Suresh H, Mithani K, Danthine V, Wong S, Coleman SC, Rutka JT, Weiss S, Sham L, Donner E, Chau V, Hadjinicolaou A, Major P, Weil AG, Tailor J, Abel TJ, Remick M, Akwayena E, Schrader D, Bollo RJ, Smyth MD, Aum D, Lew S, Wang S, Niazi T, Raskin JS, Widjaja E, Albert GW, Weiner HL, Gadgil N, LoPresti MA, Fallah A, Kerr E, Jirsa V, Jain P, Ibrahim GM

Neuromodulation : journal of the International Neuromodulation Society2026

DOI: 10.1016/j.neurom.2026.03.009 PMID: 42024054

The Current State of Care for Tuberous Sclerosis Complex in Canada

Whitney R, Nouri MN, Sham L, Muir K, Andrade AV, Connolly MB, Donner EJ, Evanochko C, Flinn J, House AA

Canadian Journal of Neurological Sciences20261 citations

DOI: 10.1017/cjn.2025.58

Diagnostic Accuracy of Clinical Manifestations in Identifying People With Tuberous Sclerosis Complex.

Li J, El Haffaf Z, Lattouf JB, Major P, Keezer MR

Neurology. Genetics2025

DOI: 10.1212/nxg.0000000000200275 PMID: 40612764

Distinct peripheral pro-inflammatory profile associated with tuberous sclerosis complex and epilepsy.

Balthazard R, Drouin-Engler RM, Bertrand S, Zine-Eddine F, Li J, Tastet O, Daigneault A, Mamane VH, Ortega-Delgado GG, Sreng Flores AM, Kaufmann DE, Major P, House AA, Létourneau-Guillon L, Arbour N, Keezer MR, Larochelle C

Epilepsia2025

DOI: 10.1111/epi.18261 PMID: 39817839

Under-recognised neurocognitive deficits in adults and adolescents with tuberous sclerosis complex.

Boisclair M, Blondeau LA, Bouchard F, Drouin-Engler RM, Li J, Bertrand S, Zine-Eddine F, Létourneau-Guillon L, Larochelle C, Major P, Boucher O, Keezer MR

Journal of medical genetics2025

DOI: 10.1136/jmg-2024-110388 PMID: 39832894

TÉCUM: A New Transition Program for Young People With Epilepsy.

Zhao YN, Blondeau LA, Drouin-Engler RM, Beaudet L, Côté M, Damiani J, Chartrand D, Léger V, Nguyen DK, Major P, Keezer MR

Neurology. Clinical practice2025

DOI: 10.1212/cpj.0000000000200541 PMID: 41282515

What defines response to vagus nerve stimulation in children with drug-resistant epilepsy? A prospective cohort study from the CONNECTiVOS collaboration.

Niazi F, Mithani K, Suresh H, Wong SM, Yau I, McRae L, Dinger TF, Rutka JT, Ochi A, Otsubo H, Weiss S, Sham L, Donner E, Chau V, Hadjinicolaou A, Major P, Weil AG, Tailor J, Abel TJ, Remick M, Akwayena E, Schrader D, Bollo RJ, Smyth MD, Aum D, Lew S, Wang S, Niazi T, Raskin JS, Widjaja E, Weiner HL, Gadgil N, LoPresti MA, Albert GW, Fallah A, Kerr E, Smith ML, Jain P, Ibrahim GM

Epilepsia2025

DOI: 10.1111/epi.18520 PMID: 40574479

Blood Biomarkers to Identify Renal Angiomyolipomas in People With Tuberous Sclerosis Complex.

Balthazard R, Li J, Loubert F, Drouin-Engler RM, Boisclair M, Coquelet P, Nguyen A, Rebillard RM, Arbour N, Major P, House AA, Larochelle C, Keezer MR

Neurology. Genetics2025

DOI: 10.1212/nxg.0000000000200276 PMID: 40661860

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Biomarkers Dear Professor Major, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Do we agree on seizure reduction after vagus nerve stimulation? Interrater reliability of retrospective and prospective seizure frequency ratings from the CONNECTiVOS database." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Peripheral and CNS inflammation and injury profiles in children with Tuberous Sclerosis Complex and their association with neurological disability and treatment with mTOR inhibitors: a multicentre, longitudinal study cohort." (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Philippe Major

Research

Latest papers

Latest funding

Do we agree on seizure reduction after vagus nerve stimulation? Interrater reliability of retrospective and prospective seizure frequency ratings from the CONNECTiVOS database.

Brain-age defines a structural signature of outcomes after vagus nerve stimulation in children.

Personalized Virtual Brain Simulations and Vagus Nerve Stimulation Outcomes in Pediatric Epilepsy: A Multicenter Study From the CONNECTiVOS Collaboration.

The Current State of Care for Tuberous Sclerosis Complex in Canada

Diagnostic Accuracy of Clinical Manifestations in Identifying People With Tuberous Sclerosis Complex.

Distinct peripheral pro-inflammatory profile associated with tuberous sclerosis complex and epilepsy.

Under-recognised neurocognitive deficits in adults and adolescents with tuberous sclerosis complex.

T&#xc9;CUM: A New Transition Program for Young People With Epilepsy.

What defines response to vagus nerve stimulation in children with drug-resistant epilepsy? A prospective cohort study from the CONNECTiVOS collaboration.

Blood Biomarkers to Identify Renal Angiomyolipomas in People With Tuberous Sclerosis Complex.

Peripheral and CNS inflammation and injury profiles in children with Tuberous Sclerosis Complex and their association with neurological disability and treatment with mTOR inhibitors: a multicentre, longitudinal study cohort.

Neuroinflammation as a biomarker for epilepsy and neuropsychiatric comorbidities among people with tuberous sclerosis complex: a prospective, multicentre study

Frequent collaborators

Anne Gallagher

Elysa Widjaja

Catherine Larochelle

Lionel Carmant

Shelly Weiss

Rajesh Ramachandran Nair

Elsa Rossignol

Myriam Srour

Myriam Srour

Ala Birca

Nathalie Arbour

Sebastien Perreault

Laurence Ducharme-Crevier

Line Beaudet

Eisha Christian

Dave Saint-Amour

Genevieve Du Pont-Thibodeau

Mark Tarnopolsky

Guillaume Bourque

Ridha Joober

Patrick Cossette

Ibrahim Mohamed

Alan So

Mathieu Dehaes

Robert Laprairie

Mark Ferro

Kathy Speechley

TÉCUM: A New Transition Program for Young People With Epilepsy.